AXSM Axsome Therapeutics, Inc.
Price Chart
Executive Summary
Director Roger Jeffs filed a Form 144 to sell 286 shares of Axsome Therapeutics common stock, valued at approximately $70,407. The shares originated from a restricted stock lapse on June 6, 2026, and the sale appears to be a routine tax-withholding transaction. The dollar amount is negligible relative to the company's $12.7B market cap, making this filing inconsequential for traders.
Actionable Insight
This is a routine, tax-motivated sale from restricted stock vesting with no trading implications. Monitor for any larger insider dispositions or changes in senior leadership selling patterns, but this filing alone does not warrant a trade action.
Key Facts
- Director Roger Jeffs filed Form 144 to sell 286 shares of common stock.
- Estimated sale value of $70,407 based on June 10, 2026 trade.
- Shares originated from a restricted stock lapse (equity compensation) on June 6, 2026.
- Sale constitutes a trivial fraction of the company's $12.7B market capitalization.
- No indication of a Rule 10b5-1 trading plan (filing marked as 'LIVE'), but size and context suggest routine tax-motivated sale.
Financial Impact
Sale of 286 shares for ~$70,407, representing ~0.0006% of AXSM's market cap.
Risk Factors
- None material — extremely small relative to market cap.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001921094-26-000636 |
| Document: 0001921094-26-000636-index.html | 0001921094-26-000636 |
| Document: 0001921094-26-000636.txt | 0001921094-26-000636 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
1d ago
|
Insider Cluster
| $253.88 awaiting T+1 | awaiting T+1 | — | $255.17 (+0.51%) |
|
Jun 11, 2026
1d ago
|
144
| $253.88 awaiting T+1 | awaiting T+1 | — | $255.17 (+0.51%) |
|
Jun 11, 2026
2d ago
|
Insider Cluster
| $246.42 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.55%) |
|
Jun 9, 2026
3d ago
|
144
| $245.68 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.86%) |
|
Jun 9, 2026
3d ago
|
8-K
| $245.68 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.86%) |
|
Jun 9, 2026
3d ago
|
Insider Cluster
| $245.68 awaiting T+1 | awaiting T+1 | — | $255.17 (+3.86%) |
|
Jun 4, 2026
9d ago
|
Press Release
| $231.48 $232.32 | ▲ +0.36% | ▲ +2.96% | $255.17 (+10.23%) |
|
Jun 3, 2026
10d ago
|
8-K
| $233.49 $231.48 | ▼ −0.86% | ▼ −1.26% | $255.17 (+9.29%) |
|
May 4, 2026
5w ago
|
8-K
| $223.70 $223.06 | ▼ −0.29% | ▼ −1.08% | $255.17 (+14.07%) |
|
May 4, 2026
5w ago
|
Press Release
| $223.70 $223.06 | ▼ −0.29% | ▼ −1.08% | $255.17 (+14.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access